Latest filing published 02 Oct 2013 for WATSON PHARMACEUTICALS INC.
No signal scores available.
Michel J. Feldman is a declared insider of Watson Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 18 filings; the first trade dates from 4 May 2007 and the latest from 1 October 2013.
No open-market purchase appears, only 6 sales worth €4.0M. The rest of the record consists of 7 share grants and 3 option exercises. So far in 2013, the count stands at no purchases and 1 sale.
The newest entry dates from 2 October 2013: a transaction, in Watson Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations